Abbott FreeStyle InsuLinx Blood Glucose Meter Recall Issued

About 50,000 Abbott blood glucose meters were recalled this week, due to a risk that they may provide inaccurate readings, which could place diabetic users at risk of severe injury or death. 

An Abbott FreeStyle Insulix Blood Glucose Meter recall was announced on April 15, indicating that the devices may malfunction and display a glucose level of 1,024 mg per deciliter lower than the actual level, causing a delay in treatment.

For example, the meters will display a reading of “10” if the true level is 1,034 mg per deciliter. This can cause life threatening situations because a blood glucose level of 1,024 is extremely high and requires immediate medical attention.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

At least one report has been identified involving problems with the Abbott FreeStyle InsuLinx meter, involving a user who required medical treatment after experiencing hyperglycemia, or high blood sugar.

Abbott Laboratories recommended that users take either of the following two actions to fix the problem:

  • Users may visit www.freestyleinsulinx.com/swupdate to download software to correct the issue. The program will maintain the settings and historical data recorded on the meters
  • Users may also contact Abbott Diabetes Care Customer Service at 1-866-723-2697 and request to return and replace the meter free of charge.

Last month Johnson & Johnson issued a recall involving nearly 2 million OneTouch Verio IQ blood glucose meters worldwide, due to a potential risk that they may fail to operate correctly at high blood glucose levels.

Johnson & Johnson as well as two other blood glucose meter manufacturers face an insulin overdose wrongful death lawsuit allegedly linked to inaccurate insulin readings from OneTouch Ultra Blood Glucose meter and test strips.

Abbott recommends that users be cautious of their symptoms until they install the software or receive new meters while still using the recalled FreeStyle Insulix as the meter may not be showing the accurate reading and users may need medical treatment.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted today)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted today)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted yesterday)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.